Direct-Acting Antiviral's Impact on Patients' Adherence to HCV Drug Regimen
May 13th 2016Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
Watch
Discussing Intentional Zika Virus Infection
May 12th 2016Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, discusses a concerning trend among individuals to purposefully infect themselves with the Zika virus, in the hopes of building up an immunity.
Watch
Discussing the VA's Decision To Supply HCV Treatment to All Veterans
April 21st 2016Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the recent decision from The Department of Veterans Affairs (VA) to supply hepatitis C (HCV) treatment to all veterans, regardless of disease stage.
Watch